Helptext

Movies



Company Information

Company NameOncology Venture Sweden AB
Company Idea

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

Phone+45 21 70 10 49CEOPeter Buhl Jensen
E-mailinfo(snabel-a)oncologyventure(punkt)comChairm. of the BoardDuncan Moore
Homepagehttp://www.oncologyventure.com 

Instrument Information

Full NameOncology VentureShort NameOV
No of shares10,877,007Par Value0.14 SEK
TypeShareISIN codeSE0007157409

Price Information

+/-0.60
%2.12
Latest28.90
High28.90
Low27.00
Volume5,179
Turnover (SEK)144,951
Market Cap (MSEK)314

Orders

VolumeBidAskVolume
53827.6028.901,229
18527.5029.00550
1,00027.1029.20175
12327.0029.603,000
79026.9030.004,725
1,41726.1030.10622
25026.0030.50187
1,38025.6030.60400
78025.5030.901,012
80025.0031.00130
10022.4031.101,014
  32.001,197
  33.80124
  34.00100
  34.50378
  36.00608
  36.401,150
  36.90600
  38.60500
  40.001,000

Deals

TimeBuyerSellerPriceVolume
11:31 AMENSNON28.9063
11:11 AMENSNON28.60600
11:11 AMENSAVA28.50500
11:11 AMENSNON28.50200
11:11 AMENSNON28.50120
11:11 AMENSAVA28.50337
11:11 AMENSAVA28.40180
10:53 AMENSAVA28.50163
10:52 AMENSAVA28.20180
10:52 AMENSMLI28.00612

Scheduled Reports

DateReport
2017-11-23Delårsrapport tre
2018-02-28Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se